Efficacy and Safety of Chinese Herbal Medicine for Endometriosis Associated Pain.

Yuezhen Lin, Ruijie Hou, Tao Zhang, J. Chung, Chi-Chiu Wang, Rui-hua Zhao
{"title":"Efficacy and Safety of Chinese Herbal Medicine for Endometriosis Associated Pain.","authors":"Yuezhen Lin, Ruijie Hou, Tao Zhang, J. Chung, Chi-Chiu Wang, Rui-hua Zhao","doi":"10.1142/S0192415X22500446","DOIUrl":null,"url":null,"abstract":"Endometriosis is a chronic, estrogen-dependent condition that causes dysmenorrhea and pelvic pain. Chinese herbal medicine (CHM) has been used for endometriosis for many years in Asian populations. This is a retrospective study in a territory teaching hospital of the China Academy of Chinese Medical Sciences in Beijing, China to compare the short- and long-term effectiveness and safety of CHM for endometriosis associated pain (EAP) before and after CHM treatment. A total of 338 out of 1143 women confirmed with endometriosis by ultrasonogram or surgery within three months received a CHM decoction twice a day for at least 3 and up to 24 months. All data were collected by a Structured Medical Records of Endometriosis (SMRE) in every clinic visit covering the whole treatment period. Pain score, evaluated by Numeric Rating Scale, was significantly decreased from 3rd to 12th month in women with moderate or severe pain. Frequency and severity rating of menstrual symptoms, evaluated by Cox Menstrual Symptom Scale, were significantly decreased in women with any pain level. Psychological changes rated by Self-rating Anxiety Scale (SAS) were significantly lower in 3, 6, 12, and 24 months of treatment, but those by Self-rating Depression Scale (SDS) was significantly decreased in six months of treatment. There was no severe adverse event but only minor side-effects. In conclusion, our study showed that CHM relieved EAP and related symptoms with minimal side-effects after treatment. A large-scale randomized and placebo-controlled trial could be designed to confirm the efficacy and safety.","PeriodicalId":94221,"journal":{"name":"The American journal of Chinese medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The American journal of Chinese medicine","FirstCategoryId":"0","ListUrlMain":"https://doi.org/10.1142/S0192415X22500446","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Endometriosis is a chronic, estrogen-dependent condition that causes dysmenorrhea and pelvic pain. Chinese herbal medicine (CHM) has been used for endometriosis for many years in Asian populations. This is a retrospective study in a territory teaching hospital of the China Academy of Chinese Medical Sciences in Beijing, China to compare the short- and long-term effectiveness and safety of CHM for endometriosis associated pain (EAP) before and after CHM treatment. A total of 338 out of 1143 women confirmed with endometriosis by ultrasonogram or surgery within three months received a CHM decoction twice a day for at least 3 and up to 24 months. All data were collected by a Structured Medical Records of Endometriosis (SMRE) in every clinic visit covering the whole treatment period. Pain score, evaluated by Numeric Rating Scale, was significantly decreased from 3rd to 12th month in women with moderate or severe pain. Frequency and severity rating of menstrual symptoms, evaluated by Cox Menstrual Symptom Scale, were significantly decreased in women with any pain level. Psychological changes rated by Self-rating Anxiety Scale (SAS) were significantly lower in 3, 6, 12, and 24 months of treatment, but those by Self-rating Depression Scale (SDS) was significantly decreased in six months of treatment. There was no severe adverse event but only minor side-effects. In conclusion, our study showed that CHM relieved EAP and related symptoms with minimal side-effects after treatment. A large-scale randomized and placebo-controlled trial could be designed to confirm the efficacy and safety.
中药治疗子宫内膜异位症相关疼痛的疗效和安全性。
子宫内膜异位症是一种慢性雌激素依赖性疾病,会导致痛经和盆腔疼痛。在亚洲人群中,中草药(CHM)已用于治疗子宫内膜异位症多年。这是一项在中国北京中国中医科学院地区教学医院进行的回顾性研究,旨在比较CHM治疗子宫内膜异位症相关疼痛(EAP)前后的短期和长期有效性和安全性。1143名妇女中,有338名在三个月内通过超声检查或手术确诊为子宫内膜异位症,她们接受了CHM煎剂治疗,每天两次,至少持续3个月,最长持续24个月。所有数据均通过子宫内膜异位症结构化医疗记录(SMRE)在整个治疗期间的每次就诊中收集。从第3个月到第12个月,中度或重度疼痛的女性的疼痛评分通过数字评定量表进行评估,显著降低。Cox月经症状量表评估的月经症状的频率和严重程度在任何疼痛水平的女性中都显著降低。焦虑自评量表(SAS)评定的心理变化在治疗的3、6、12和24个月内显著降低,而抑郁自评量量表(SDS)评定的则在治疗的6个月内明显降低。没有严重的不良事件,只有轻微的副作用。总之,我们的研究表明,CHM在治疗后以最小的副作用缓解了EAP和相关症状。可以设计一项大规模的随机和安慰剂对照试验来确认疗效和安全性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信